Federated Hermes’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,828	Closed	-$17.3K	–	2061
2025 Q1	$17.3K	Sell	11,828 -11,543	-49%	-$21.8K	﹤0.01%	1746
2024 Q4	$49.8K	Buy	23,371 +3,640	+18%	+$8.98K	﹤0.01%	1665
2024 Q3	$55.2K	Buy	19,731 +7,431	+60%	+$19.8K	﹤0.01%	1639
2024 Q2	$28.7K	Buy	+12,300	New	+$36.3K	﹤0.01%	1683
2023 Q3	–	Sell	-170	Closed	-$845	–	2092
2023 Q2	$845	Hold	170	–	–	﹤0.01%	2031
2023 Q1	$840	Sell	170 -273,683	-100%	-$1.76M	﹤0.01%	2052
2022 Q4	$1.72M	Buy	273,853 +273,810	+636,767%	+$2.53M	﹤0.01%	959
2022 Q3	$1K	Hold	43	–	–	﹤0.01%	2003
2022 Q2	$1K	Sell	43 -58,650	-100%	-$521K	﹤0.01%	2019
2022 Q1	$535K	Buy	+58,693	New	+$611K	﹤0.01%	1436
2021 Q1	–	Sell	-16,044	Closed	-$405K	–	2215
2020 Q4	$405K	Sell	16,044 -68,044	-81%	-$2.22M	﹤0.01%	1567
2020 Q3	$3.17M	Sell	84,088 -33,619	-29%	-$1.27M	0.01%	849
2020 Q2	$5.04M	Buy	+117,707	New	+$4.26M	0.01%	712
2019 Q2	–	Sell	-175,000	Closed	-$5.06M	–	2159
2019 Q1	$5.06M	Hold	175,000	–	–	0.01%	787
2018 Q4	$4.71M	Buy	+175,000	New	+$4.65M	0.01%	747